
C Taz 500mg/62.5mg Injection
Marketer
Emcure Pharmaceuticals Ltd
Salt Composition
Ceftriaxone (500mg) + Tazobactum (62.5mg)
Overview C Taz 500mg/62.5mg Injection
The antibiotic injection, C Taz (500mg/62.5mg), is a dual-action formulation combating diverse bacterial infections. Its mechanism inhibits microbial proliferation, curbing infection spread. Administration must be solely under a doctor's guidance; adhere strictly to the prescribed schedule. Complete the entire treatment course, even with symptom improvement; premature cessation can compromise its effectiveness. Nausea, vomiting, diarrhea, and dyspepsia are potential side effects; escalating symptoms necessitate immediate medical attention. Seek emergency care for allergic reactions (rash, itching, swelling, dyspnea). Disclose all current medications to your physician before commencing treatment. Pregnant or lactating individuals require prior medical consultation. Alcohol consumption should be avoided due to potential increased drowsiness. While generally driving ability is unaffected, refrain from driving if experiencing somnolence or dizziness. Adequate rest, nutritious food, and ample hydration are crucial for optimal recovery. Your physician may order tests to monitor treatment efficacy.
Uses of C Taz 500mg/62.5mg Injection
Infections caused by bacteria
Major Benefits of C Taz 500mg/62.5mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of C Taz 500mg/62.5mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use C Taz 500mg/62.5mg Injection:
The medication will be administered by your physician or their qualified assistant; self-medication is strictly prohibited.
How C Taz 500mg/62.5mg Injection works:
Ceftriaxone and Tazobactum, combined as C Taz 500 mg/62.5 mg Injection, offer a dual-action approach to bacterial infection. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their ability to thrive. Tazobactum's role as a beta-lactamase inhibitor counteracts bacterial defenses, augmenting Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from ingesting alcohol while using C Taz 500 mg/62.5 mg Injection.
PregnancySAFE IF PRESCRIBED
Ceftriaxone/Sulbactam 500 mg/62.5 mg injection is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nevertheless, clinical data in humans are scarce.
Breast feedingCAUTION
Ceftazidime/Tazobactam 500 mg/62.5 mg injection requires careful consideration during lactation. Mothers should discontinue breastfeeding throughout the treatment course and until the medication is fully cleared from their system.
DrivingUNSAFE
The combined medication C Taz 500 mg/62.5 mg Injection can induce drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects manifest.
KidneyCONSULT YOUR DOCTOR
Data regarding the use of C Taz 500 mg/62.5 mg Injection in individuals with renal impairment is scarce. Physician consultation is advised.
LiverCAUTION
The 500 mg/62.5 mg C Taz injection requires careful administration in patients exhibiting severe hepatic impairment; dosage modification may be necessary. Consult your physician for guidance. Dosage alteration for this injection is not advised for individuals with mild or moderate liver dysfunction.
What if you forget to take C Taz 500mg/62.5mg Injection :
Should you forget a scheduled dose of C Taz 500 mg/62.5 mg Injection, seek your physician's advice.
Facts to Know About C Taz 500mg/62.5mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
